|
|
Volumn 62, Issue 2, 2003, Pages 108-109
|
|
New results from studies of therapy of ankylosing spondylitis with infliximab;Neue Studienergebnisse zur Therapie der Spondylitis ankylosans mit Infliximab.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIRHEUMATIC AGENT;
INFLIXIMAB;
MONOCLONAL ANTIBODY;
TUMOR NECROSIS FACTOR ALPHA;
ANKYLOSING SPONDYLITIS;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DRUG ANTAGONISM;
FOLLOW UP;
HUMAN;
IMMUNOLOGY;
RANDOMIZED CONTROLLED TRIAL;
ANTIBODIES, MONOCLONAL;
ANTIRHEUMATIC AGENTS;
FOLLOW-UP STUDIES;
HUMANS;
RANDOMIZED CONTROLLED TRIALS;
SPONDYLITIS, ANKYLOSING;
TUMOR NECROSIS FACTOR-ALPHA;
|
|
EID: 0242320698
PISSN: 03401855
EISSN: None
Source Type: Journal
DOI: 10.1007/s00393-003-0501-3 Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|
